These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 94316)

  • 21. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
    Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
    Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of infusion with hydroxyethyl starch and low molecular weight dextran on cerebral blood flow and hemorheology in normal baboons.
    Tsuda Y; Hartmann A; Weiand J; Solymosi L
    J Neurol Sci; 1987 Dec; 82(1-3):171-80. PubMed ID: 2450177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of an equal volume replacement with 500 mL 6% hydroxyethyl starch on the blood and plasma volume of healthy volunteers.
    Mortelmans Y; Merckx E; van Nerom C; Verbruggen A; van Aken H; de Roo M; Mortelmans L
    Eur J Anaesthesiol; 1995 May; 12(3):259-64. PubMed ID: 7543845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Flow characteristics of blood and its therapeutic modification].
    Reinhart WH
    Schweiz Med Wochenschr; 1987 May; 117(18):693-7. PubMed ID: 3589626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W; Pölz W; Colombo T; Steindorfer P
    Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the effect of microstructural changes of blood on energy dissipation in Couette flow.
    Kaliviotis E; Yianneskis M
    Clin Hemorheol Microcirc; 2008; 39(1-4):235-42. PubMed ID: 18503131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rheologic findings in patients with diabetic retinopathy].
    Bertram B; Wolf S; Kaufhold F; Jung F; Kiesewetter H; Reim M
    Fortschr Ophthalmol; 1991; 88(4):321-5. PubMed ID: 1786912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of red cell aggregation by low shear rate viscometry in whole blood with elevated plasma viscosity.
    Janzen J; Elliott TG; Carter CJ; Brooks DE
    Biorheology; 2000; 37(3):225-37. PubMed ID: 11026942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
    Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
    Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
    Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mathematical decription of the human intravascular elimination of HAS after repeated infusions].
    Mishler JM; Beez M
    Infusionsther Klin Ernahr; 1979 Apr; 6(2):119-22. PubMed ID: 85606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers.
    Ferber HP; Nitsch E; Förster H
    Arzneimittelforschung; 1985; 35(3):615-22. PubMed ID: 2581591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Conjunctival oxygen partial pressure, hemorheology and circulatory parameters in acute cerebral infarct before and following infusion of 6 percent low molecular hydroxyethyl starch].
    Kortsik CS; Staedt U; Stein T; Geiger G; Buss J
    Infusionstherapie; 1990 Apr; 17(2):79-82. PubMed ID: 1693909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant.
    Marotta F; Safran P; Tajiri H; Princess G; Anzulovic H; Idéo GM; Rouge A; Seal MG; Idéo G
    Hepatogastroenterology; 2001; 48(38):511-7. PubMed ID: 11379344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood, plasma, erythrocyte viscosity and index of erythrocyte filtration in subjects with hyperlipemia].
    Craveri A; Tornaghi G; Paganardi L; Lanfredini M; Citella C; Leonardi G
    Minerva Med; 1987 Jun; 78(12):823-9. PubMed ID: 3601130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red blood cell aggregation during cardiopulmonary bypass: a pathogenic cofactor in endothelial cell activation?
    Morariu AM; Gu YJ; Huet RC; Siemons WA; Rakhorst G; Oeveren WV
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):939-46. PubMed ID: 15519186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of Expafusion (HES 40/0.5) on the corpuscular elements of blood and inhibitors of blood coagulation].
    Köstering H; Giffhorn J; Negendank-Damenz B
    Infusionsther Klin Ernahr; 1985 Dec; 12(6):304-7. PubMed ID: 2419250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
    Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of a parenteral fish-oil preparation (Omegaven) on erythrocyte morphology and blood viscosity in vitro.
    Fischler L; Meredith DO; Reinhart WH
    Clin Hemorheol Microcirc; 2003; 28(2):79-88. PubMed ID: 12652013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.